retatrutide trial dosing just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Retatrutide peptide 20mg: complete dosing

The pill is also approved to help reduce the risk of serious cardiovascular events like nonfatal heart attacks and strokes

But Your Honor, when you control for weight loss, those effects disappear or diminish substantially

We were quite excited by the findings, as this study was the first to demonstrate a physiological role of GLP-1 in appetite control and energy intake in humans

16 Qinna NA, Akayleh FT, Al-Remawi MM, Kamona BS, Taha H, Badwan AA

Hypoglycemia: While less common with GLP-1 receptor agonists like semaglutide compared to some other diabetes medications, hypoglycemia (low blood sugar) can still occur

The pharmacokinetics explain everything